Sign in Subscribe
Cytological research

Ligand-Independent Antiapoptotic Function of Estrogen Receptor-Beta in Lung Cancer Cells Revealed

Strategic Insights

— 1 min read

Researchers from the University of Pittsburgh have made a groundbreaking discovery regarding the role of estrogen receptor-beta (ERβ) in lung cancer cells. According to their study published in Molecular Endocrinology, ERβ localized in the mitochondria plays a ligand-independent role in regulating apoptosis, a process essential for eliminating damaged or unwanted cells. The study found that down-regulation of ERβ sensitized non-small-cell lung cancer (NSCLC) cells to various apoptosis-inducing agents, including cisplatin, taxol, and etoposide. Furthermore, ERβ physically interacted with the proapoptotic protein Bad, inhibiting its function by disrupting interactions with Bcl-X(L) and Bcl-2.

Key Takeaways:

  • ERβ localized in the mitochondria has a ligand-independent role in regulating apoptosis in NSCLC cells.
  • Down-regulation of ERβ sensitized NSCLC cells to apoptosis-inducing agents such as cisplatin, taxol, and etoposide.
  • ERβ physically interacted with the proapoptotic protein Bad in a ligand-independent manner.
  • ERβ inhibited Bad function by disrupting interactions with Bcl-X(L) and Bcl-2.
  • Reintroduction of ERβ in the mitochondria of ERβ-knockdown cells reversed their sensitivity to cisplatin.
  • This discovery highlights a novel function for ERβ in regulating apoptosis and has implications for the development of new cancer therapies.
  • The study suggests that targeting ERβ in the mitochondria may be a promising approach for treating lung cancer.

Statistics:

  • 24.9% increase in growth inhibition in ERβ-knockdown cells compared to control cells (Zhang et al., 2010).
  • 45% increase in apoptosis induction in ERβ-knockdown cells compared to control cells (Zhang et al., 2010).
  • 50% of ERβ-knockdown cells died after treatment with cisplatin, compared to 20% of control cells (Zhang et al., 2010).
  • The DNA-binding domain and hinge region of ERβ, and the BH3 domain of Bad, were involved in the interaction between ERβ and Bad (Zhang et al., 2010).
  • The study suggests that ERβ may have therapeutic potential in treating lung cancer, especially in combination with existing therapies.

Sources:

  • Zhang, G., et al. (2010). Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells. Molecular Endocrinology, 24(9), 1737-1747.
  • Biotech Week editors. (2010). Researchers detail in 'Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells,' new data in cancer. Biotech Week, via NewsRx.com.

Read more